Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
243.54
-1.25 (-0.51%)
At close: Jul 19, 2024, 4:00 PM
245.00
+1.46 (0.60%)
Pre-market: Jul 22, 2024, 5:38 AM EDT
Danaher Revenue
Danaher had revenue of $22.52B in the twelve months ending March 29, 2024. Revenue in the quarter ending March 29, 2024 was $5.80B. In the year 2023, Danaher had annual revenue of $23.89B.
Revenue (ttm)
$22.52B
Revenue Growth
-9.58%
P/S Ratio
8.01
Revenue / Employee
$357,444
Employees
63,000
Market Cap
180.39B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
Dec 31, 2014 | 12.87B | -5.42B | -29.62% |
Dec 31, 2013 | 18.28B | 22.70M | 0.12% |
Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
Dec 31, 2005 | 7.87B | 982.20M | 14.26% |
Dec 31, 2004 | 6.89B | 1.60B | 30.14% |
Dec 31, 2003 | 5.29B | 716.64M | 15.66% |
Dec 31, 2002 | 4.58B | 794.79M | 21.01% |
Dec 31, 2001 | 3.78B | 4.67M | 0.12% |
Dec 31, 2000 | 3.78B | 580.54M | 18.16% |
Dec 31, 1999 | 3.20B | 150.18M | 4.93% |
Dec 31, 1998 | 3.05B | 427.96M | 16.34% |
Dec 31, 1997 | 2.62B | 385.91M | 17.28% |
Dec 31, 1996 | 2.23B | 746.42M | 50.20% |
Dec 31, 1995 | 1.49B | 372.80M | 33.47% |
Dec 31, 1994 | 1.11B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck & Co. | 61.40B |
Pfizer | 55.09B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Amgen | 29.53B |
DHR News
- 4 days ago - Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development - PRNewsWire
- 5 days ago - Danaher Releases 2024 Sustainability Report - PRNewsWire
- 10 days ago - Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening - PRNewsWire
- 13 days ago - Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer - PRNewsWire
- 27 days ago - Danaher Schedules Second Quarter 2024 Earnings Conference Call - PRNewsWire
- 4 weeks ago - Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics - PRNewsWire
- 4 weeks ago - Global Flow Cytometry Industry Outlook Report, 2024-2032: Market Dynamics, Technology Insights, Patent Analysis (2014-2024), and Profiles of Leading Players Including BD and Danaher - GlobeNewsWire
- 6 weeks ago - Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer - PRNewsWire